Stockholders’ Deficiency |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Equity [Abstract] | |
| Stockholders’ Deficiency | Stockholders’ Deficiency Common Stock The Company has the authority to issue 1,000,000,000 shares of common stock, $0.01 par value per share. Restricted Stock Units – The Company issued, in connection with the vesting of restricted stock units,7,860 and 7,499 shares of the Company’s common stock during the three months ended March 31, 2026 and 2025, respectively, as reflected on the condensed consolidated statements of stockholders’ deficiency. Common Stock Withheld – The Company recorded the repurchase of 0 shares related to vested restricted common stock for the payment for taxes of $0 during the three months ended March 31, 2026, and the repurchase of 2,814 shares related to vested restricted common stock for the payment for taxes of $4 during the three months ended March 31, 2025, as reflected on the condensed consolidated statements of stockholders’ deficiency.
|